Covered recipient · General Payments record
JOSSEF AMIRIAN
General Payments · PY2018–2024
$6,117.90
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $484.72 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ShockWave Medical, Inc | $185.83 | 1 |
| Medtronic, Inc. | $170.53 | 2 |
| Amgen Inc. | $49.38 | 2 |
| Actelion Pharmaceuticals US, Inc. | $31.73 | 2 |
| E.R. Squibb & Sons, L.L.C. | $26.69 | 1 |
| Novo Nordisk AS | $20.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $17.50 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078904039 | CMS |
| Actelion Pharmaceuticals US, Inc. | $14.23 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078904043 | CMS |
| Amgen Inc. | $21.37 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111516567 | CMS |
| Amgen Inc. | $28.01 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111516569 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.69 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101369006 | CMS |
| Medtronic, Inc. | $28.96 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116861174 | CMS |
| Medtronic, Inc. | $141.57 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116861172 | CMS |
| Novo Nordisk Inc | $20.56 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582643 | CMS |
| ShockWave Medical, Inc | $185.83 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152982110 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.